Mel Chisholm opens up about battling a eating disorder, describing binge-eating episodes, therapy and her recovery ...

BLOOM (TAMPA) – Binge eating is surprisingly one of the most common yet misrepresented eating disorders. Gayle Guyardo, host ...

We live in an era where scrolling through social media almost guarantees you'll encounter someone preaching the gospel of ...

“I struggled with binging and restricting mostly,” the former ‘DWTS’ pro said ...

We’re in our wellness era, whether we want to be or not. “What I eat in a day” videos, green smoothies, and fitness influencers are dominating our social media feeds, and somewhere along the way, ...

This story was featured in The Must Read, a newsletter in which our editors recommend one can’t-miss story every weekday. Sign up here to get it in your inbox. For me, the last two months of the year ...

When Chevese Turner first discussed Ozempic with her doctor to treat her diabetes, she was both worried and relieved. Finally, “there was something effective that [was] going to address my diabetes,” ...

Eating disorders can harm a person's physical and mental health in ways that linger for years, a new study reports. Anorexia, bulimia, binge eating and other such disorders bring with them a high risk ...

Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly’s GLP-1 weight-loss drug appeared to temporarily suppress food-craving signals in the ...

New research out of the University of Pennsylvania has helped identify how major weight-loss drugs suppress so-called "food noise" in the brain. "Developing new ways to treat these patients is of the ...

Brain monitoring shows tirzepatide reduces food cravings Binge-eating signals were suppressed in the nucleus accumbens, the brain's reward center Effect seen in a single patient was only temporary GLP ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, in New York City, U.S., December ...